Stockadora

8-K filings / November 18, 2026

IMPACT BIOMEDICAL INC.: A stock exchange listing notice

IMPACT BIOMEDICAL INC. filed a current report (Form 8-K) with the SEC on November 18, 2026. It reports a stock exchange listing notice.

Item 3.01

Stock exchange listing notice

  • Exchange NYSE American From the filing
    Source
    “On the Closing Date, the Company notified NYSE American that the Merger had been completed and requested that NYSE American (i) suspend trading of the Company Common Stock prior to the open of trading on November 18, 2026, (ii) withdraw the Company’s Common Stock from listing on NYSE American, and (iii) file with the SEC a notification of removal from listing on Form 25 to delist the Company Common Stock from NYSE American and deregister the Company Common Stock under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).”
    Read by code from this sentence of the filing.
  • What it says The stock leaves the exchange after a merger From the filing
    Source
    “On the Closing Date, the Company notified NYSE American that the Merger had been completed and requested that NYSE American (i) suspend trading of the Company Common Stock prior to the open of trading on November 18, 2026, (ii) withdraw the Company’s Common Stock from listing on NYSE American, and (iii) file with the SEC a notification of removal from listing on Form 25 to delist the Company Common Stock from NYSE American and deregister the Company Common Stock under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).”
    Read by code from this sentence of the filing.
  • Notice date November 18, 2026 From the filing
    Source
    “On the Closing Date, the Company notified NYSE American that the Merger had been completed and requested that NYSE American (i) suspend trading of the Company Common Stock prior to the open of trading on November 18, 2026, (ii) withdraw the Company’s Common Stock from listing on NYSE American, and (iii) file with the SEC a notification of removal from listing on Form 25 to delist the Company Common Stock from NYSE American and deregister the Company Common Stock under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).”
    Read by code from this sentence of the filing.
Not investment advice.Read the filing on SEC.gov

Item 5.02

Officers and directors

The filing also carries this item, but our code could not read it surely, so its facts are not shown here.

Not investment advice.Read the filing on SEC.gov

Facts read from the filing's own text; a fact the filing does not state clearly is left out. All documents of this filing on SEC.gov.